Crossmark Global Holdings, Inc. Davita Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.49 Billion
Q4 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Davita Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 30,769 shares of DVA stock, worth $5.18 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

30,769

Previous 25,827 19.14%

Holding current value

$5.18 Million

Previous $4.23 Million 8.67%

% of portfolio

0.08%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$139.81 - $167.96 $690,941 - $830,058	4,942 Added 19.14%	30,769 $4.6 Million
Q3 2024 Nov 04, 2024	BUY	$133.98 - $165.19 $923,926 - $1.14 Million	6,896 Added 36.43%	25,827 $4.23 Million
Q2 2024 Jul 29, 2024	BUY	$126.11 - $147.14 $32,788 - $38,256	260 Added 1.39%	18,931 $2.62 Million
Q1 2024 May 13, 2024	BUY	$103.89 - $139.21 $121,655 - $163,014	1,171 Added 6.69%	18,671 $2.58 Million
Q4 2023 Feb 13, 2024	SELL	$73.2 - $108.8 $412,189 - $612,652	-5,631 Reduced 24.34%	17,500 $1.83 Million
Q3 2023 Nov 08, 2023	BUY	$94.53 - $112.68 $263,833 - $314,489	2,791 Added 13.72%	23,131 $2.11 Million
Q2 2023 Jul 31, 2023	BUY	$81.58 - $100.93 $712,356 - $881,320	8,732 Added 75.22%	20,340 $2.06 Million
Q1 2023 May 12, 2023	BUY	$74.68 - $85.82 $340,839 - $391,682	4,564 Added 64.79%	11,608 $941,000
Q4 2022 Jan 19, 2023	BUY	$65.42 - $99.31 $60,513 - $91,861	925 Added 15.12%	7,044 $526,000
Q3 2022 Nov 01, 2022	SELL	$80.24 - $95.27 $203,007 - $241,033	-2,530 Reduced 29.25%	6,119 $507,000
Q2 2022 Jul 29, 2022	BUY	$76.05 - $123.38 $183,280 - $297,345	2,410 Added 38.63%	8,649 $692,000
Q1 2022 May 11, 2022	SELL	$108.37 - $120.0 $391,215 - $433,200	-3,610 Reduced 36.65%	6,239 $705,000
Q4 2021 Jan 10, 2022	SELL	$94.5 - $116.95 $1.11 Million - $1.38 Million	-11,760 Reduced 54.42%	9,849 $1.12 Million
Q3 2021 Oct 21, 2021	BUY	$116.26 - $133.78 $1.38 Million - $1.59 Million	11,869 Added 121.86%	21,609 $2.51 Million
Q3 2021 Oct 13, 2021	SELL	$116.26 - $133.78 $1.57 Million - $1.81 Million	-13,509 Reduced 58.11%	9,740 $505,000
Q2 2021 Jul 21, 2021	SELL	$105.44 - $127.98 $176,084 - $213,726	-1,670 Reduced 6.7%	23,249 $2.8 Million
Q1 2021 Apr 15, 2021	SELL	$99.98 - $123.89 $345,930 - $428,659	-3,460 Reduced 12.19%	24,919 $2.69 Million
Q4 2020 Jan 14, 2021	BUY	$82.82 - $117.4 $1.66 Million - $2.35 Million	20,000 Added 238.69%	28,379 $3.33 Million
Q3 2020 Oct 08, 2020	SELL	$79.57 - $91.84 $79,570 - $91,840	-1,000 Reduced 10.66%	8,379 $718,000
Q2 2020 Aug 14, 2020	SELL	$65.52 - $88.28 $26,797 - $36,106	-409 Reduced 4.18%	9,379 $742,000
Q1 2020 Apr 28, 2020	SELL	$64.99 - $88.5 $37,564 - $51,153	-578 Reduced 5.58%	9,788 $744,000
Q4 2019 Feb 06, 2020	SELL	$54.2 - $75.03 $976,846 - $1.35 Million	-18,023 Reduced 63.49%	10,366 $778,000
Q3 2019 Oct 09, 2019	SELL	$52.55 - $63.28 $63,007 - $75,872	-1,199 Reduced 4.05%	28,389 $1.62 Million
Q2 2019 Jul 09, 2019	SELL	$43.42 - $57.79 $77,721 - $103,444	-1,790 Reduced 5.7%	29,588 $1.67 Million
Q1 2019 May 02, 2019	BUY	$49.95 - $59.21 $499 - $592	10 Added 0.03%	31,378 $1.7 Million
Q4 2018 Jan 31, 2019	BUY	$48.73 - $76.08 $442,127 - $690,273	9,073 Added 40.7%	31,368 $1.61 Million
Q3 2018 Nov 08, 2018	SELL	$66.51 - $74.55 $47,222 - $52,930	-710 Reduced 3.09%	22,295 $1.6 Million
Q2 2018 Jul 31, 2018	SELL	$62.77 - $73.47 $8,787 - $10,285	-140 Reduced 0.6%	23,005 $1.6 Million
Q1 2018 Apr 16, 2018	SELL	$65.0 - $80.03 $131,170 - $161,500	-2,018 Reduced 8.02%	23,145 $1.53 Million
Q4 2017 Feb 05, 2018	BUY	$53.89 - $72.36 $88,918 - $119,394	1,650 Added 7.02%	25,163 $1.82 Million
Q3 2016 Oct 25, 2017	BUY	N/A	23,513	23,513 $1.4 Million

Others Institutions Holding DVA

# of Institutions

655

Shares Held

74.4M

Call Options Held

1.41M

Put Options Held

1.82M

View Full List

About DAVITA INC.

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $15.4B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

More about DVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Davita Inc. Transaction History